Product Images Nalbuphine Hydrochloride

This text provides information about Nalbuphine Hydrochloride Injection with a concentration of 200 mg/10 mL (20 mg/mL) in a multiple-dose flip-top vial. It includes details on the composition, instructions for use, storage conditions, and distributor information. The injection is suitable for intravenous, intramuscular, or subcutaneous administration and contains nalbuphine HC!, buffers, and preservatives. The usual dosage instructions are specified in the insert. Users are advised to follow aseptic techniques during usage. The injectable must be protected from light and stored at room temperature. The manufacturer is NDG with lot number and expiration date provided.*

This text provides information about a 10 mL multiple-dose solution for intravenous, subcutaneous, or intramuscular use. It is distributed by Hospira, Inc. and contains nalbuphine HCI along with other ingredients such as buffers and preservatives. The solution is sterile, nonpyrogenic, and should be protected from light and stored at controlled room temperature. The lot number, expiration date, and prescription-only notice are also included in the text.*

This text appears to be a detailed description of a medication labeled as "Auoxy 184." The medication is in a flip-top vial for single-dose use and contains nalbuphine HCI, sodium chrate, dihydrate, clric acid, anhydrous, methylparaben, and propylparaben as well as other buffers and preservatives. It advises on dosage, aseptic technique, and to protect from light. The vendor/distributor is Hospira, Inc. This product is to be stored at 20-25°C and should be kept in its carton until ready for use. Additional information includes lot and expiration details along with how to prepare it for use. It appears to be intended for intravenous, intramuscular, or subcutaneous use.*